Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Ryden

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|June 10, 2004
Promoting heart health--a European consensusEmer Shelley, Lars Ryden
Herz|September 2, 2004
Diabetes and the heartThomas F Lüscher, Lars Ryden, Diethelm Tschöpe
Pacing and Clinical Electrophysiology : PACE|June 16, 2005
Development of implantable devices for continuous ambulatory monitoring of central hemodynamic values in heart failure patientsTom Bennett, Barbro Kjellstrom, Robert Taepke, et al.
European Journal of Heart Failure|August 11, 2004
Six years follow-up of an implanted SvO(2) sensor in the right ventricleBarbro Kjellström, Cecilia Linde, Tom Bennett, et al.
American Heart Journal|December 18, 2007
Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention), Hertzel Gerstein, Salim Yusuf, et al.
Peptides|July 16, 2003
Glucagon-like peptide-1 (7-36) amide prevents the accumulation of pyruvate and lactate in the ischemic and non-ischemic porcine myocardiumMohammad Kavianipour, Mario R Ehlers, Klas Malmberg, et al.
The American Journal of Medicine|March 12, 2019
The Medical Profession, Industry, and Continuing Medical Education: Finding the Balance That's Right for PatientsPeter Kearney, Maarten Simoons, Lars Ryden, et al.
European Heart Journal|November 9, 2006
Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heartMattie Lenzen, Lars Ryden, John Ohrvik, et al.
Diabetes & Vascular Disease Research|May 19, 2016
Copeptin, insulin-like growth factor binding protein-1 and sitagliptin: A report from the BEta-cell function in Glucose abnormalities and Acute Myocardial Infarction studyLisa Arnetz, Camilla Hage, Kerstin Brismar, et al.
International Journal of Cardiology|September 12, 2020
Peripheral arterial disease and intermittent claudication in coronary heart disease patientsŽeljko Reiner, Johan De Sutter, Lars Ryden, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|June 10, 2004
Promoting heart health--a European consensusEmer Shelley, Lars Ryden
Herz|September 2, 2004
Diabetes and the heartThomas F Lüscher, Lars Ryden, Diethelm Tschöpe
Pacing and Clinical Electrophysiology : PACE|June 16, 2005
Development of implantable devices for continuous ambulatory monitoring of central hemodynamic values in heart failure patientsTom Bennett, Barbro Kjellstrom, Robert Taepke, et al.
European Journal of Heart Failure|August 11, 2004
Six years follow-up of an implanted SvO(2) sensor in the right ventricleBarbro Kjellström, Cecilia Linde, Tom Bennett, et al.
American Heart Journal|December 18, 2007
Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention), Hertzel Gerstein, Salim Yusuf, et al.
Peptides|July 16, 2003
Glucagon-like peptide-1 (7-36) amide prevents the accumulation of pyruvate and lactate in the ischemic and non-ischemic porcine myocardiumMohammad Kavianipour, Mario R Ehlers, Klas Malmberg, et al.
The American Journal of Medicine|March 12, 2019
The Medical Profession, Industry, and Continuing Medical Education: Finding the Balance That's Right for PatientsPeter Kearney, Maarten Simoons, Lars Ryden, et al.
European Heart Journal|November 9, 2006
Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heartMattie Lenzen, Lars Ryden, John Ohrvik, et al.
Diabetes & Vascular Disease Research|May 19, 2016
Copeptin, insulin-like growth factor binding protein-1 and sitagliptin: A report from the BEta-cell function in Glucose abnormalities and Acute Myocardial Infarction studyLisa Arnetz, Camilla Hage, Kerstin Brismar, et al.
International Journal of Cardiology|September 12, 2020
Peripheral arterial disease and intermittent claudication in coronary heart disease patientsŽeljko Reiner, Johan De Sutter, Lars Ryden, et al.
Pageof 5